Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefanie Mesch

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Chimia|December 9, 2010
From the ganglioside GQ1balpha to glycomimetic antagonists of the myelin-associated glycoprotein (MAG)Beat Ernst, Oliver Schwardt, Stefanie Mesch, et al.
Chemmedchem|October 13, 2011
From a library of MAG antagonists to nanomolar CD22 ligandsStefanie Mesch, Katrin Lemme, Matthias Wittwer, et al.
Bioorganic & Medicinal Chemistry|May 18, 2007
Synthesis of sialic acid derivatives as ligands for the myelin-associated glycoprotein (MAG)Sachin V Shelke, Gan-Pan Gao, Stefanie Mesch, et al.
Carbohydrate Research|April 3, 2010
Kinetic and thermodynamic properties of MAG antagonistsStefanie Mesch, Katrin Lemme, Hendrik Koliwer-Brandl, et al.
Bioorganic & Medicinal Chemistry|September 17, 2010
Design, synthesis, biological evaluation, and modeling of a non-carbohydrate antagonist of the myelin-associated glycoproteinOliver Schwardt, Hendrik Koliwer-Brandl, Raphael Zimmerli, et al.
Journal of Medicinal Chemistry|January 30, 2009
Examination of the biological role of the alpha(2-->6)-linked sialic acid in gangliosides binding to the myelin-associated glycoprotein (MAG)Oliver Schwardt, Heiko Gäthje, Angelo Vedani, et al.
Journal of Medicinal Chemistry|January 26, 2010
Low molecular weight antagonists of the myelin-associated glycoprotein: synthesis, docking, and biological evaluationStefanie Mesch, Delia Moser, Daniel S Strasser, et al.
Journal of Medicinal Chemistry|November 21, 2019
Discovery and Characterization of the Potent and Selective P2X4 Inhibitor <i>N</i>-[4-(3-Chlorophenoxy)-3-sulfamoylphenyl]-2-phenylacetamide (BAY-1797) and Structure-Guided Amelioration of Its CYP3A4 Induction ProfileStefan Werner, Stefanie Mesch, Roman C Hillig, et al.
Journal of Medicinal Chemistry|January 9, 2023
Discovery of <b>BAY-390</b>, a Selective CNS Penetrant Chemical Probe as Transient Receptor Potential Ankyrin 1 (TRPA1) AntagonistStefanie Mesch, Daryl Walter, Alexis Laux-Biehlmann, et al.
Journal of Medicinal Chemistry|June 11, 2025
Discovery of BAY 3389934 Hydrochloride: A Potent and Selective Small-Molecule Dual Factor IIa/Xa Inhibitor with Short Half-Life for the Acute Treatment of Sepsis-Induced CoagulopathyHartmut Beck, Stefanie Mesch, Stefanie Zimmermann, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Chimia|December 9, 2010
From the ganglioside GQ1balpha to glycomimetic antagonists of the myelin-associated glycoprotein (MAG)Beat Ernst, Oliver Schwardt, Stefanie Mesch, et al.
Chemmedchem|October 13, 2011
From a library of MAG antagonists to nanomolar CD22 ligandsStefanie Mesch, Katrin Lemme, Matthias Wittwer, et al.
Bioorganic & Medicinal Chemistry|May 18, 2007
Synthesis of sialic acid derivatives as ligands for the myelin-associated glycoprotein (MAG)Sachin V Shelke, Gan-Pan Gao, Stefanie Mesch, et al.
Carbohydrate Research|April 3, 2010
Kinetic and thermodynamic properties of MAG antagonistsStefanie Mesch, Katrin Lemme, Hendrik Koliwer-Brandl, et al.
Bioorganic & Medicinal Chemistry|September 17, 2010
Design, synthesis, biological evaluation, and modeling of a non-carbohydrate antagonist of the myelin-associated glycoproteinOliver Schwardt, Hendrik Koliwer-Brandl, Raphael Zimmerli, et al.
Journal of Medicinal Chemistry|January 30, 2009
Examination of the biological role of the alpha(2-->6)-linked sialic acid in gangliosides binding to the myelin-associated glycoprotein (MAG)Oliver Schwardt, Heiko Gäthje, Angelo Vedani, et al.
Journal of Medicinal Chemistry|January 26, 2010
Low molecular weight antagonists of the myelin-associated glycoprotein: synthesis, docking, and biological evaluationStefanie Mesch, Delia Moser, Daniel S Strasser, et al.
Journal of Medicinal Chemistry|November 21, 2019
Discovery and Characterization of the Potent and Selective P2X4 Inhibitor <i>N</i>-[4-(3-Chlorophenoxy)-3-sulfamoylphenyl]-2-phenylacetamide (BAY-1797) and Structure-Guided Amelioration of Its CYP3A4 Induction ProfileStefan Werner, Stefanie Mesch, Roman C Hillig, et al.
Journal of Medicinal Chemistry|January 9, 2023
Discovery of <b>BAY-390</b>, a Selective CNS Penetrant Chemical Probe as Transient Receptor Potential Ankyrin 1 (TRPA1) AntagonistStefanie Mesch, Daryl Walter, Alexis Laux-Biehlmann, et al.
Journal of Medicinal Chemistry|June 11, 2025
Discovery of BAY 3389934 Hydrochloride: A Potent and Selective Small-Molecule Dual Factor IIa/Xa Inhibitor with Short Half-Life for the Acute Treatment of Sepsis-Induced CoagulopathyHartmut Beck, Stefanie Mesch, Stefanie Zimmermann, et al.
Pageof 2